Company logo

ULBI - Ultralife Corporation

NASDAQ -> Industrials -> Electrical Equipment & Parts
Newark, United States
Type: Equity

ULBI price evolution
ULBI
(in millions $) 30 Oct 2024 30 Jun 2024 31 Mar 2024 31 Jan 2024
Current assets
Cash $6.77 $6.69 $10.1 $10.28
Short term investments
Net receivables $27.75 $31.05 $35.28 $31.76
Inventory $43.99 $41.39 $43.82 $42.22
Total current assets $86.43 $83.79 $94.3 $90.2
Long term investments
Property, plant & equipment $24.44 $20.28 $20.67 $21.12
Goodwill & intangible assets $52.16 $52.37 $52.68
Total noncurrent assets $86.03 $86.25 $88.07
Total investments
Total assets $172.44 $169.82 $180.55 $178.28
Current liabilities
Accounts payable $12.68 $9.69 $13.31 $11.34
Deferred revenue
Short long term debt $2 $2 $2
Total current liabilities $26.2 $20.57 $23.38 $23.73
Long term debt $5.89 $9.98 $23.14 $23.62
Total noncurrent liabilities $15.9 $28.23 $29.12
Total debt $11.98 $25.14 $25.62
Total liabilities $37.96 $36.47 $51.61 $52.94
Shareholders' equity
Retained earnings -$34.64 -$34.89 -$37.86 -$40.75
Other shareholder equity -$3.08 -$3.9 -$3.89 -$3.66
Total shareholder equity $133.21 $128.84 $125.33
(in millions $) 31 Jan 2024 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $10.28 $5.71 $8.41 $10.65
Short term investments
Net receivables $31.76 $27.78 $20.23 $21.05
Inventory $42.22 $41.19 $33.19 $28.19
Total current assets $90.2 $78.99 $66.52 $64.5
Long term investments
Property, plant & equipment $21.12 $21.72 $23.2 $22.85
Goodwill & intangible assets $52.68 $53.35 $55.46 $36.23
Total noncurrent assets $88.07 $89.44 $93.01 $73.2
Total investments
Total assets $178.28 $168.43 $159.54 $137.7
Current liabilities
Accounts payable $11.34 $16.07 $9.82 $10.84
Deferred revenue
Short long term debt $2 $2 $2 $1.36
Total current liabilities $23.73 $28.91 $18.92 $18.71
Long term debt $23.62 $19.31 $18.86
Total noncurrent liabilities $29.12 $23.11 $22.87 $2.07
Total debt $25.62 $21.31 $20.86 $1.36
Total liabilities $52.94 $52.15 $41.8 $20.78
Shareholders' equity
Retained earnings -$40.75 -$47.95 -$47.83 -$47.6
Other shareholder equity -$3.66 -$3.75 -$1.65 -$1.78
Total shareholder equity $125.33 $116.28 $117.62 $116.8
(in millions $) 30 Oct 2024 30 Jun 2024 31 Mar 2024 31 Jan 2024
Revenue
Total revenue $42.98 $41.93 $44.55
Cost of revenue $31.42 $30.46
Gross Profit $11.56 $11.47 $11.4
Operating activities
Research & development $2 $1.76
Selling, general & administrative $5.65 $5.65
Total operating expenses $7.65 $7.41 $7.75
Operating income $3.92 $4.06
Income from continuing operations
EBIT $4.24 $4.11
Income tax expense $0.85 $0.7 $0.26
Interest expense $0.42 $0.52
Net income
Net income $2.97 $2.89 $2.87
Income (for common shares) $2.97 $2.89
(in millions $) 31 Jan 2024 31 Dec 2022 31 Jan 2022 31 Dec 2020
Revenue
Total revenue $158.64 $131.84 $107.71
Cost of revenue $102.44 $78.55
Gross Profit $39.2 $29.4 $29.16
Operating activities
Research & development $7.08 $5.95
Selling, general & administrative $22.19 $17.51
Total operating expenses $29.73 $29.27 $23.46
Operating income $0.13 $5.7
Income from continuing operations
EBIT $0.51 $7.36
Income tax expense $1.95 -$0.33 $1.69
Interest expense $0.95 $0.44
Net income
Net income $7.2 -$0.12 $5.23
Income (for common shares) -$0.12 $5.23
(in millions $) 30 Oct 2024 30 Jun 2024 31 Mar 2024 31 Dec 2023
Net income $2.97 $2.89 $2.87
Operating activities
Depreciation $1.02 $0.97 $0.97
Business acquisitions & disposals
Stock-based compensation $0.16 $0.16 $0.1
Total cash flows from operations $8.93 -$0.08 $2.43
Investing activities
Capital expenditures -$0.36 -$0.37 -$1
Investments
Total cash flows from investing -$1.33 -$0.36 -$0.37 -$1
Financing activities
Dividends paid
Sale and purchase of stock $1.25 $0.69 $0.21
Net borrowings -$13.18 -$0.5 -$0.5
Total cash flows from financing -$15.82 -$11.93 $0.18 -$0.3
Effect of exchange rate $0.05 -$0.05 $0.09 -$0.15
Change in cash and equivalents -$3.5 -$3.41 -$0.18 $0.98
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income $7.2 -$0.12 -$0.23 $5.23
Operating activities
Depreciation $3.91 $4.46 $3.54 $2.94
Business acquisitions & disposals -$23.52
Stock-based compensation $0.53 $0.78 $0.67 $0.94
Total cash flows from operations $1.93 -$1.26 $4.33 $21.72
Investing activities
Capital expenditures -$2.55 -$1.68 -$2.81 -$2.98
Investments
Total cash flows from investing -$2.55 -$1.68 -$26.33 -$2.98
Financing activities
Dividends paid
Sale and purchase of stock $1.25 $0.12 $0.4 $0.24
Net borrowings $4.25 $0.42 $19.39 -$15.84
Total cash flows from financing $5.49 $0.52 $19.64 -$15.69
Effect of exchange rate -$0.3 -$0.28 $0.13 $0.2
Change in cash and equivalents $4.57 -$2.7 -$2.24 $3.25
News
Is There Now An Opportunity In Ultralife Corporation (NASDAQ:ULBI)?
Simply Wall St. · via Yahoo Finance 4 Dec 2024
Ultralife Corporation (ULBI): A Bull Case Theory
Insider Monkey · via Yahoo Finance 17 Nov 2024
Is Ultralife Corporation (ULBI) the Best High Growth Lithium Stock to Invest In?
Insider Monkey · via Yahoo Finance 18 Oct 2024
Ultralife Expands Portfolio with Electrochem Acquisition
TipRanks · via Yahoo Finance 5 Oct 2024
Ultralife Corporation (ULBI): One of the Best Battery Stocks to Buy According to...
Insider Monkey · via Yahoo Finance 19 Sep 2024
Ultralife Corporation (ULBI): Hedge Funds Are Bullish On This Lithium Stock...
Insider Monkey · via Yahoo Finance 19 Sep 2024
Ultralife (NASDAQ:ULBI) shareholders have earned a 122% return over the last...
Simply Wall St. · via Yahoo Finance 19 Jul 2024
What Is Ultralife Corporation's (NASDAQ:ULBI) Share Price Doing?
Simply Wall St. · via Yahoo Finance 18 Jun 2024
Ultralife Corporation (NASDAQ:ULBI) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance 30 Apr 2024
Can Mixed Fundamentals Have A Negative Impact on Ultralife Corporation (NASDAQ:ULBI) Current Share...
Simply Wall St. via Yahoo Finance 8 Mar 2024
Fundamentals
Market cap $129.02M
Enterprise value N/A
Shares outstanding 16.63M
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share 0.41
EPS N/A
ROA N/A
ROE N/A
Debt/Equity 0.42
Net debt/EBITDA N/A
Current ratio 3.30
Quick ratio 1.62